Amedeo Smart

Free Medical Literature Service

 

Amedeo

Colorectal Neoplasms
  Free Subscription

Articles published in
PLoS One
    January 2026
  1. DANTAS AAG, Oliveira NPD, Martins LFL, de Camargo Cancela M, et al
    Social determinants in the delay of starting colorectal cancer treatment.
    PLoS One. 2026;21:e0338727.
    >> Share

  2. SCHOENAKER IJH, van Westreenen HL, Finnema EJ, Schrauwen R, et al
    Diagnostic performance of eNose technology in detecting colorectal cancer recurrence: A prospective evaluation.
    PLoS One. 2026;21:e0340276.
    >> Share

  3. MECHLEB K, Hourani N, Fakhry M, Alyamani OA, et al
    Targeting ceramide metabolism to restore hypoxia-induced apoptosis in p53-deficient colon cancer cells.
    PLoS One. 2026;21:e0340295.
    >> Share


  4. Editorial Note: The multi-targeted kinase inhibitor sunitinib induces apoptosis in colon cancer cells via PUMA.
    PLoS One. 2026;21:e0339805.
    >> Share

  5. DUAN Z, Li Y, Ren G, Tan M, et al
    Relationships among social support, decision self-efficacy, and decision regret in colorectal chemotherapy cancer patients: A mediating model.
    PLoS One. 2026;21:e0339927.
    >> Share

  6. GUO F, Li J, Chen L, Hu J, et al
    Radiomics profiling combined with clinical risk factors for preoperative Lymphatic Metastasis prediction in Colorectal cancer: A multicenter study.
    PLoS One. 2026;21:e0340352.
    >> Share

  7. BENNASRALLAH C, Maatouk A, Kacem M, Dhouib W, et al
    Colorectal cancer incidence, survival analysis and predictions (Monastir, Tunisia: 2002-2030).
    PLoS One. 2026;21:e0339603.
    >> Share

  8. SCHNEIDER JL, Rivelli JS, Escaron AL, Crocker R, et al
    Impact of COVID-19 on colorectal cancer screening in a federally qualified health center: Provider and staff perspectives.
    PLoS One. 2026;21:e0340184.
    >> Share

  9. ZHOU D, Zhou J, Hu B, Yu Y, et al
    Prognostic value of tumor deposits and their different response to neoadjuvant therapy in locally advanced rectal cancer.
    PLoS One. 2026;21:e0340000.
    >> Share

  10. JIANG L, Peng Z, Liu R, Chen L, et al
    A study on the effect of CBSM-based psychological intervention on self-management ability and quality of life in colorectal cancer patients from the perspective of benefit finding: A quasi-experimental study.
    PLoS One. 2026;21:e0339472.
    >> Share

  11. IBRAHEEM W, Alsheikh F, Alzain AA, Bhongade BA, et al
    Computational repurposing of approved drugs targeting KRAS G12D and EGFR for colorectal cancer therapy.
    PLoS One. 2026;21:e0338123.
    >> Share


  12. Retraction: Arctigenin inhibits the progression of colorectal cancer through epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway.
    PLoS One. 2026;21:e0341384.
    >> Share

  13. ZHANG XF, Zhang XL, Xu HW, Lin YH, et al
    ITIH2 in colorectal cancer metastasis: Weighted Gene Co-expression Network Analysis-guided functional validation.
    PLoS One. 2026;21:e0329719.
    >> Share

  14. ZUBAIR NF, Mohammed Nawi A, Hassan MR, Daud A, et al
    Multilevel factors influencing colorectal cancer screening adherence: A systematic literature review.
    PLoS One. 2026;21:e0342184.
    >> Share

  15. SONG S, Zhang Y, Li L, Zhou K, et al
    Nucleolar protein 6 as a potential oncogenic factor in colorectal cancer.
    PLoS One. 2026;21:e0340047.
    >> Share


  16. Correction: Diagnostic performance of eNose technology in detecting colorectal cancer recurrence: A prospective evaluation.
    PLoS One. 2026;21:e0342238.
    >> Share

  17. TATSUTA K, Sakata M, Iwaizumi M, Okamoto K, et al
    Clinical impact of hospital distance and center transfers on adherence and outcomes in familial adenomatous polyposis: A multicenter retrospective study in a defined region of Japan.
    PLoS One. 2026;21:e0339401.
    >> Share

  18. BUNSUK T, Chantaraamporn J, Mutapat P, Diskul Na Ayudthaya P, et al
    Reducing OGT and O-GlcNAcylation enhance the anticancer effects of oxaliplatin in SW620 metastatic colorectal cancer cells.
    PLoS One. 2026;21:e0341971.
    >> Share

  19. KIM HS, Kim J, Lee B, Lee Y, et al
    The role of exosomal miRNA-125b derived from colon cancer-associated fibroblasts in skeletal muscle cachexia.
    PLoS One. 2026;21:e0342052.
    >> Share

  20. WANG Z, Ma L, Sun Z, Lv H, et al
    Elucidating key targets and mechanisms of diethyl phthalate-induced colorectal cancer through network toxicology and molecular docking.
    PLoS One. 2026;21:e0343038.
    >> Share


  21. Expression of Concern: A practical approach for colorectal cancer diagnosis based on machine learning.
    PLoS One. 2026;21:e0343787.
    >> Share


  22. Retraction: omega3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients.
    PLoS One. 2026;21:e0343572.
    >> Share

  23. LIN L, Ying Y, Shu L, Lv X, et al
    Association between different metabolic obesity phenotypes and colorectal adenoma.
    PLoS One. 2026;21:e0343556.
    >> Share

  24. PADUANO G, Di Giuseppe G, Postiglione M, Nese G, et al
    Assessment of the adherence and willingness to participate in colorectal cancer screening programs among people living in prison.
    PLoS One. 2026;21:e0344256.
    >> Share

  25. VILKOITE I, Silamikelis I, Klovins J, Tolmanis I, et al
    Colorectal adenoma presence is associated with decreased menaquinone pathway functions in the gut microbiome of patients undergoing routine colonoscopy.
    PLoS One. 2026;21:e0344050.
    >> Share

  26. LI J, Zhang J, Ke J, Ren Z, et al
    Integrative network pharmacology and machine learning identify potential targets of indole-3-lactic acid in colorectal cancer.
    PLoS One. 2026;21:e0344478.
    >> Share

  27. DE KLERK M, Bartels EA, Timmers J, Nahar-van Venrooij LMW, et al
    Person-centered care, shared decision-making, and service modularity in colorectal cancer treatment: A mixed-method study of patient and professional perspectives.
    PLoS One. 2026;21:e0343331.
    >> Share

  28. FARAHMAND P, Rzasa P, Green C, Hey F, et al
    Phosphorylations of serines 21/9 in glycogen synthase kinase 3alpha/beta are dispensable for V600EBRAF-driven premalignant tumour development in the mouse intestine.
    PLoS One. 2026;21:e0337259.
    >> Share

  29. HOAD KL, Ton C, Williamson D, Subar DA, et al
    The role of prehabilitation in improving brain health and cognition after chemotherapy in patients with colorectal cancer: Study protocol of the Chemo Brain Prehab Project.
    PLoS One. 2026;21:e0341996.
    >> Share

  30. THOMPSON JH, Schneider JL, Rivelli JS, Gautom P, et al
    Implementing a successful patient navigation program for follow-up colonoscopy: Lessons from the PRECISE study.
    PLoS One. 2026;21:e0343659.
    >> Share

  31. KHAWAJA G, Shoujaa A, El-Orfali Y, Abou Najem S, et al
    Swertiamarin fails to induce cytotoxicity in colon cancer cell lines: Evidence against a direct anticancer effect.
    PLoS One. 2026;21:e0344653.
    >> Share

  32. LIU X, Han Y, Kuang R, Sheng W, et al
    HMGB1 reduce DNA damage by binding KU70 to activate NHEJ pathway in colorectal cancer cells after radiation.
    PLoS One. 2026;21:e0345635.
    >> Share

  33. CORONADO GD, Dickerson JF, Tsou MH, Shivaprakash N, et al
    Temporal and geographic analyses of colorectal cancer screening during and after the COVID-19 pandemic in a federally qualified health center.
    PLoS One. 2026;21:e0345248.
    >> Share

  34. SANCHEZ MA, Mercier G, Clement MC, Ortega-Deballon P, et al
    Future impacts of colectomy healthcare pathways on quality of care in bundled payment experiments, a national retrospective cohort in France.
    PLoS One. 2026;21:e0346558.
    >> Share

  35. CAI B, Lin B, Song C, Lu Z, et al
    Is there a "weekend effect" in adenoma detection rate?A single-center retrospective study.
    PLoS One. 2026;21:e0345613.
    >> Share

  36. HERRERA-RAMIREZ A, Becerra-Quintana R, Yepes AF, Cardona-Galeano W, et al
    Novel benzofuran/pterostilbene hybrids trigger programmed cell death and impair migration in CRC cells.
    PLoS One. 2026;21:e0344602.
    >> Share

  37. YANG J, Morhard R, Huth H, Karim B, et al
    Antitumoral immunity induced by gel ethanol ablation to treat unresectable colorectal cancer metastases in the liver.
    PLoS One. 2026;21:e0347625.
    >> Share

  38. FERNANDEZ FIGUEROA EA, Falcon-Martinez JC, Garcia-Gordillo JA, Coquis-Navarrete U, et al
    Beyond individual markers: Prognostic value of the combined CEA/PNI score in metastatic colorectal cancer as a predictor of survival.
    PLoS One. 2026;21:e0346932.
    >> Share

  39. BURGOS-BRAGADO JM, Jimenez-Sanchez C, Brandin-de la Cruz N, Carpallo-Porcar B, et al
    Asynchronous telerehabilitation in prehabilitation and postoperative recovery for colorectal cancer: A protocol for a randomized controlled trial.
    PLoS One. 2026;21:e0333649.
    >> Share

    January 2025
  40. KANG SJ, Park J, Choi GS, Kim JG, et al
    Effects of maximum dose on local control after stereotactic body radiotherapy for oligometastatic tumors of colorectal cancer.
    PLoS One. 2025;20:e0313438.
    >> Share

  41. LEE H, Ko DS, Heo HJ, Baek SE, et al
    Uncovering NK cell sabotage in gut diseases via single cell transcriptomics.
    PLoS One. 2025;20:e0315981.
    >> Share

  42. DYER CEF, Jin F, Roberts JM, Poynten IM, et al
    Self- versus clinician-collected swabs in anal cancer screening: A clinical trial.
    PLoS One. 2025;20:e0312781.
    >> Share

  43. AYERS GD, Cohen AS, Bae SW, Wen X, et al
    Reproducibility and repeatability of 18F-(2S, 4R)-4-fluoroglutamine PET imaging in preclinical oncology models.
    PLoS One. 2025;20:e0313123.
    >> Share

  44. DUARTE AX, Silva KA, Ferreira IB, Gontijo CA, et al
    Increased consumption of ultra-processed foods and worse diet quality in colorectal cancer patients after colostomy: A prospective study.
    PLoS One. 2025;20:e0310320.
    >> Share

  45. KUMAR V, Golzarri-Arroyo L, Roth S, Imperiale TF, et al
    Effect of the COVID-19 pandemic on colorectal cancer screening in two university-affiliated health care systems.
    PLoS One. 2025;20:e0317057.
    >> Share

  46. LI Q, Li Y, Zhou T, Zhang Y, et al
    FBXW7 metabolic reprogramming inhibits the development of colon cancer by down-regulating the activity of arginine/mToR pathways.
    PLoS One. 2025;20:e0317294.
    >> Share

  47. ZHENG A, Xu H, Tao Y, Chen B, et al
    Comparative evaluation of TNM staging systems (eighth vs. ninth edition) for the non-surgical treatment of localized and locally advanced anal squamous cell carcinoma: Prognostic significance of T classification and lymph node status.
    PLoS One. 2025;20:e0317598.
    >> Share

  48. ANOSOVA O, Head A, Collins B, Alexiou A, et al
    Estimating the burden of underdiagnosis within England: A modelling study of linked primary care data.
    PLoS One. 2025;20:e0313877.
    >> Share

  49. HE Y, Liu F, Li Q, Jiang Z, et al
    Identification of cuproptosis and ferroptosis-related subtypes and development of a prognostic signature in colon cancer.
    PLoS One. 2025;20:e0307013.
    >> Share

  50. MULENGA M, Rajamanikam A, Kumar S, Muhammad SB, et al
    Revolutionizing colorectal cancer detection: A breakthrough in microbiome data analysis.
    PLoS One. 2025;20:e0316493.
    >> Share

  51. GUO R, Wei W
    Association between lipid accumulation product and the risk of colon cancer in adults: A population-based study.
    PLoS One. 2025;20:e0317462.
    >> Share

  52. SUN Y, Zhou T, Ye S, Lau EYT, et al
    Exploration of different quantitative polymerase chain reaction-based genotyping methods to distinguish Apcmin/+ mice from wildtype mice.
    PLoS One. 2025;20:e0317038.
    >> Share

  53. JIRAMITMONGKON K, Rotkrua P, Khanchaitit P, Arunpanichlert J, et al
    Multifunctional molecular hybrid for targeted colorectal cancer cells: Integrating doxorubicin, AS1411 aptamer, and T9/U4 ASO.
    PLoS One. 2025;20:e0317559.
    >> Share

  54. CAZORLA G, Redmond NM, Lamouroux A, Boirot A, et al
    Acceptability and implementation potential of colorectal cancer screening and health literacy training: A qualitative study among general practitioners in deprived areas.
    PLoS One. 2025;20:e0317910.
    >> Share

  55. HUANG M, Li J, Huang W, Zhou Y, et al
    The effectiveness of Evodia rutaecarpa hot compress on the recovery of gastrointestinal function after laparoscopic surgery for colorectal cancer: A propensity score-matched retrospective cohort study.
    PLoS One. 2025;20:e0303951.
    >> Share

  56. KOUDAHL CONRAD JB, Vesterman Henriksen T, Berg Nors J, Heilskov Rasmussen M, et al
    The role of renal and liver function in clinical ctDNA testing.
    PLoS One. 2025;20:e0319194.
    >> Share

  57. LI L, Ji Z, Li G, Gu H, et al
    FAM50A as a novel prognostic marker modulates the proliferation of colorectal cancer cells via CylinA2/CDK2 pathway.
    PLoS One. 2025;20:e0318776.
    >> Share

  58. TOMIMATSU H, Fujimoto K, Suto T, Matsuo M, et al
    Prognosis of extracolonic findings on clinical computed tomographic colonography: A single-center experience.
    PLoS One. 2025;20:e0315601.
    >> Share

  59. MALLARI MA, Singh A, Shubella J, Khaliq W, et al
    Cancer screening prevalence and preference among hospitalized women with and without diabetes mellitus.
    PLoS One. 2025;20:e0319681.
    >> Share

  60. BOVINDER YLITALO E, Vidman L, Harlid S, Van Guelpen B, et al
    mRNA extracted from frozen buffy coat samples stored long term in tubes with no RNA preservative shows promise for downstream sequencing analyses.
    PLoS One. 2025;20:e0318834.
    >> Share

  61. LANGIU M, Crescence L, Mege D, Dubois C, et al
    Consequences of platelet-educated cancer cells on the expression of inflammatory and metastatic glycoproteins.
    PLoS One. 2025;20:e0317096.
    >> Share

  62. MIGNOZZI S, De Pinto G, Guglielmetti S, Riso P, et al
    Role of aspirin on colorectal cancer risk and bacterial translocation to bloodstream.
    PLoS One. 2025;20:e0319750.
    >> Share

  63. WANG Y, Chen B, Yu J
    A machine learning-based model for predicting survival in patients with Rectosigmoid Cancer.
    PLoS One. 2025;20:e0319248.
    >> Share

  64. OHASHI Y, Miyo M, Okuya K, Akizuki E, et al
    Impact of double-bolus tracking to individualize scan timing of the portal venous phase in preoperative computed tomography colonography angiography for right-sided colon cancer.
    PLoS One. 2025;20:e0320630.
    >> Share

  65. MOTOSUGI S, Takahashi N, Mineo S, Sato K, et al
    Enrichment of Porphyromonas gingivalis in colonic mucosa-associated microbiota and its enhanced adhesion to epithelium in colorectal carcinogenesis: Insights from in vivo and clinical studies.
    PLoS One. 2025;20:e0320383.
    >> Share

  66. WANG Y, Feng S, Chen J, Li Y, et al
    Association between serum 25-hydroxyvitamin D concentration and the risk of colorectal cancer: A cross-sectional study.
    PLoS One. 2025;20:e0320335.
    >> Share

  67. MAHMUD S, Ajadee A, Sarker A, Ahmmed R, et al
    Exploring common genomic biomarkers to disclose common drugs for the treatment of colorectal cancer and hepatocellular carcinoma with type-2 diabetes through transcriptomics analysis.
    PLoS One. 2025;20:e0319028.
    >> Share

  68. CHERAGHI-SHAVI T, Jalal R, Minuchehr Z, Mahjoubi F, et al
    Correction: TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach.
    PLoS One. 2025;20:e0322319.
    >> Share

  69. ALSADHAN N, Brennan C, Alhurishi SA, Shuweihdi F, et al
    Factors influencing colorectal cancer screening decisions among Saudi women: A qualitative study.
    PLoS One. 2025;20:e0321086.
    >> Share

  70. JIANG L, Liu R, Wang F, Tan X, et al
    Development of a psychological management intervention protocol for colorectal cancer patients: a Delphi study on benefit finding.
    PLoS One. 2025;20:e0321396.
    >> Share

  71. WANG Q, Zeng L, Gao L, Xu H, et al
    The longitudinal relationship between depression and anxiety in colorectal cancer patients undergoing chemotherapy and family caregivers: A cross lagged panel model.
    PLoS One. 2025;20:e0319622.
    >> Share

  72. WU J, Dong Y, Zhu W, Meng J, et al
    Capecitabine metronomic chemotherapy for metastatic colorectal cancer patients reaching NED: A protocol for a prospective, randomized, controlled trial.
    PLoS One. 2025;20:e0320591.
    >> Share

  73. MARTINEZ-RIOS J, Lopez-Pacheco CP, Garcia-Zepeda EA, Soldevila G, et al
    CCR9 shapes the immune microenvironment of colorectal cancer modulating the balance between intratumoral CD8+ T cell and FoxP3+ Helios+ Treg subpopulations.
    PLoS One. 2025;20:e0321930.
    >> Share

  74. HAI MINH N, Quy TQ, Tam ND, Tuan TM, et al
    A practical approach for colorectal cancer diagnosis based on machine learning.
    PLoS One. 2025;20:e0321009.
    >> Share

  75. MCCREADY TM, Cohen EM, Laynor G, Chebli P, et al
    Addressing the immigrant screening gap: A protocol for a systematic review on interventions to enhance colorectal cancer screening among immigrants in the United States.
    PLoS One. 2025;20:e0322038.
    >> Share

  76. SANCHEZ-SANTIESTEBAN D, Patino-Benavidez AF, Buitrago G
    Socioeconomic inequalities of 3-year survival in formal employees with colorectal cancer between 2012 and 2019 in Colombia.
    PLoS One. 2025;20:e0316061.
    >> Share

  77. KANG D, Li J, Li Y, Xu J, et al
    Prognostic significance of KRAS, NRAS, BRAF, and PIK3CA mutations in stage II/III colorectal cancer: A retrospective study and meta-analysis.
    PLoS One. 2025;20:e0320783.
    >> Share

  78. SONDEJ D, Pigon-Zajac D, Jaszek M, Stefaniuk D, et al
    Is laccase from medicinal mushroom Cerrena unicolor cytotoxic to colon cancer cell line CT-26?
    PLoS One. 2025;20:e0322211.
    >> Share

  79. WANG J, Li J, Huo J, Zhao Y, et al
    Fibrinogen and colorectal cancer: A study of the Chinese population.
    PLoS One. 2025;20:e0322789.
    >> Share

  80. DITE GS, Wong CK, Gafni A, Spaeth E, et al
    Colorectal cancer risk prediction using a simple multivariable model.
    PLoS One. 2025;20:e0321641.
    >> Share

  81. PHILIBERT R, Beach SRH, Mills JA, Dawes K, et al
    Epigenetic assessments of alcohol consumption predict mortality in smokers at risk for lung cancer in the prostate, lung, colorectal and ovarian cancer screening trial.
    PLoS One. 2025;20:e0322783.
    >> Share

  82. YANG L, Chen X, Zhong M, Pan Z, et al
    Multivariable prediction of early malignancy detection among first-degree relatives of patients with hereditary colorectal cancer based on the health belief model: A cross-sectional study from the largest hereditary colorectal cancer cohort in China.
    PLoS One. 2025;20:e0323369.
    >> Share

  83. STRUSKI L, Urbanczyk T, Bucki K, Cupial B, et al
    MeVGAN: GAN-based plugin model for video generation with applications in colonoscopy.
    PLoS One. 2025;20:e0312038.
    >> Share

  84. GROSSMANNOVA K, Belvoncikova P, Puzderova B, Simko V, et al
    Carbonic anhydrase IX downregulation linked to disruption of HIF-1, NFkappaB and STAT3 pathways as a new mechanism of ibuprofen anti-cancer effect.
    PLoS One. 2025;20:e0323635.
    >> Share

  85. JIN'O Y, Ushikai M, Komaki Y, Masuda K, et al
    Involvement of community pharmacy pharmacists in fecal immunochemical test screening without government support in Japan.
    PLoS One. 2025;20:e0322879.
    >> Share

  86. JEON H, Lee JL, Shim H, Joe S, et al
    Genetic variations and recurrence in stage III Korean colorectal cancer: Insights from tumor-only mutation analysis.
    PLoS One. 2025;20:e0323302.
    >> Share

  87. RAHIMI F, Rezayatmand R, Dalvand Z, Ravankhah Z, et al
    Factors influencing participation in colorectal cancer screening among average-risk populations: A descriptive-analytical study in a developing country.
    PLoS One. 2025;20:e0323291.
    >> Share

  88. SAITO H, Murakami M, Ozaki A, Nishikawa Y, et al
    Estimating the impact of missed colorectal cancer diagnoses on life expectancy in Minamisoma City following the 2011 triple disaster.
    PLoS One. 2025;20:e0324822.
    >> Share

  89. ZHOU Q, Qian L, Shen C, Bei X, et al
    Automated VMAT planning for short-course radiotherapy in locally advanced rectal cancer.
    PLoS One. 2025;20:e0325567.
    >> Share

  90. CURTIS AA, Yu Y, Carey M, Yilmaz YE, et al
    A genome-wide SNP-SNP interaction analysis exploring novel interacting loci associated with the risk of recurrence in colorectal cancer.
    PLoS One. 2025;20:e0321967.
    >> Share

  91. SHAYKEVICH A, Chae D, Silverman I, Goel S, et al
    Modulating autophagy in KRAS mutant colorectal cancer using combination of oncolytic reovirus and carbamazepine.
    PLoS One. 2025;20:e0326029.
    >> Share

  92. WU W, Li A, Singh V, Salner A, et al
    Pain, fatigue, and associated gene expressions over chemotherapy in patients with colorectal cancer.
    PLoS One. 2025;20:e0325849.
    >> Share

  93. CHO NY, Kim S, Hadaya J, Chervu N, et al
    Association of center-level operative volume and acute outcomes following robotic-assisted colectomy for colorectal cancer.
    PLoS One. 2025;20:e0299174.
    >> Share

  94. ABDELMAKSOUD-DAMMAK R, Ammous-Boukhris N, Saadallah-Kallel A, Ayed-Guerfali DB, et al
    Genetic profiling of inherited colorectal cancer syndromes in Tunisian patients.
    PLoS One. 2025;20:e0326343.
    >> Share

  95. AOKI Y, Miki A, Sakuma Y, Watanabe J, et al
    Clinical impact of low bone mineral density in patients with colorectal cancer liver metastasis undergoing hepatectomy.
    PLoS One. 2025;20:e0324719.
    >> Share

  96. GEBREAL A, Abdeltawab K, Hesham O, Kolkas S, et al
    Mapping the colorectal cancer patient journey in Egypt: A qualitative study of diagnosis, treatment, and lifestyle perspectives.
    PLoS One. 2025;20:e0326144.
    >> Share

  97. ZHANG H, Wang D, Tong Z, Xiang T, et al
    Biweekly CAPOX versus triweekly CAPOX in the adjuvant therapy of post-surgery CRC: A randomized controlled trial.
    PLoS One. 2025;20:e0313472.
    >> Share


  98. Retraction: Role of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: Effect on tumor angiogenesis and cell proliferation.
    PLoS One. 2025;20:e0328096.
    >> Share

  99. FAZAL M, Kanwal S, Raza MT, Razzaque A, et al
    Exploring entropy measures with topological indices on colorectal cancer drugs using curvilinear regression analysis and machine learning approaches.
    PLoS One. 2025;20:e0327369.
    >> Share

  100. KLDIASHVILI E, Abiatari I, Kekelia E, Iordanishvili S, et al
    SOX2, PIWI proteins, and MALAT1 - plasma-based emerging biomarkers for cancer detection and monitoring.
    PLoS One. 2025;20:e0328557.
    >> Share

  101. WANG YW, Huang ZY, Jin CX, Shen XH, et al
    Unveiling the link: Evaluating MTHFR gene polymorphisms and colorectal cancer risk through meta-analysis.
    PLoS One. 2025;20:e0305517.
    >> Share

  102. LI D, Cai Q, Xu F, Lin L, et al
    Unraveling SREBF1's role in elevating colorectal cancer prognosis through proliferation and migration inhibition.
    PLoS One. 2025;20:e0327503.
    >> Share


  103. Retraction: Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/beta-catenin signal pathway.
    PLoS One. 2025;20:e0328012.
    >> Share

  104. QIU X, Li R, Xie G, Ning N, et al
    In vitro 3D drug sensitivity testing for patient-derived tumor-like cell clusters and whole-exome sequencing to personalize postoperative treatment: A study protocol for a multicenter randomized controlled trial.
    PLoS One. 2025;20:e0326760.
    >> Share


  105. Retraction: Berberine inhibits invasion and metastasis of colorectal cancer cells via COX-2/PGE2 mediated JAK2/STAT3 signaling pathway.
    PLoS One. 2025;20:e0328009.
    >> Share

  106. YANG M, Narasimhan VM, Zhan FB
    Spatial insights into colorectal cancer risk factors and priority areas for screening in the United Kingdom based on data from the UK Biobank.
    PLoS One. 2025;20:e0328778.
    >> Share

  107. YAO C, Hu M, Zhou L, Chen H, et al
    Establishment of two pathomic-based machine learning models to predict CLCA1 expression in colon adenocarcinoma.
    PLoS One. 2025;20:e0328220.
    >> Share

  108. WANG Y, Yuan Z, Lao Y, He J, et al
    Mechanistic investigation of glycolysis and pyroptosis in colon adenocarcinoma tissues, and prognostic analysis of patient clinical outcomes.
    PLoS One. 2025;20:e0328560.
    >> Share

  109. WANG ZY, Shi GX, Wang Y, Pei W, et al
    Electroacupuncture versus sham electroacupuncture in treating low anterior resection syndrome after rectal cancer surgery: Study protocol for a randomized controlled trial.
    PLoS One. 2025;20:e0329035.
    >> Share


  110. Retraction: Chemopreventive Evaluation of a Schiff Base Derived Copper (II) Complex against Azoxymethane-Induced Colorectal Cancer in Rats.
    PLoS One. 2025;20:e0328986.
    >> Share

  111. BAI F, Yin H, Zhang S, Wei D, et al
    Effect of individualized PEEP on lung ultrasound score and optic nerve sheath diameter in elderly patients undergoing laparoscopic rectal cancer surgery: A randomized controlled trial.
    PLoS One. 2025;20:e0328067.
    >> Share

  112. TSAI MH, Vo JB, Moore JX, Ramin C, et al
    Mediating effects of mental and physical health on the association between chronic disease conditions and colorectal cancer screening utilization among breast cancer survivors.
    PLoS One. 2025;20:e0328353.
    >> Share

  113. BOIROT A, Addamiano MC, Casanova C, Redmond NM, et al
    Acceptability and implementation potential of a health literacy intervention to increase colorectal cancer screening in deprived areas: A qualitative study of patients and general practitioners participating in a cluster randomized controlled trial.
    PLoS One. 2025;20:e0329639.
    >> Share

  114. KHATRI RB, Endalamaw A, Darssan D, Assefa Y, et al
    A scoping review of the levels, implementation strategies, enablers, and barriers to cervical, breast, and colorectal cancer screening among migrant populations in selected English-speaking high-income countries.
    PLoS One. 2025;20:e0329854.
    >> Share

  115. LEE Y, Silva SG, Gonzalez-Guarda RM
    Social determinants of health, health behaviors, and general health among colorectal cancer survivors: A cross-sectional study.
    PLoS One. 2025;20:e0329752.
    >> Share

  116. CHEN N, Zang B, Chen Y
    Predicting one-year post-surgical recurrence in colorectal liver metastasis using CT radiomics and machine learning.
    PLoS One. 2025;20:e0330828.
    >> Share

  117. TAKAMI T, Itatani Y, Yoshida Y, Hoshino N, et al
    Protocol for a study to evaluate the safety and efficacy of prophylactic negative pressure wound therapy after abdominal perineal resection (VACPAC study).
    PLoS One. 2025;20:e0331361.
    >> Share

  118. TABASSUM N, Hossan ME, Islam MM, Hasan M, et al
    Cheminformatics-based screening and evaluation of phytochemicals as CDK2 inhibitors in colorectal cancer therapy.
    PLoS One. 2025;20:e0331438.
    >> Share

  119. WANG J, Li J, Huo J, Zhao Y, et al
    Correction: Fibrinogen and colorectal cancer: A study of the Chinese population.
    PLoS One. 2025;20:e0332402.
    >> Share

  120. BIE AKL, Handberg Juul Martiny F, Jauernik CP, Rahbek OJ, et al
    Physical harms in colorectal cancer screening: An overview of the reporting in systematic reviews and randomised controlled trials.
    PLoS One. 2025;20:e0331104.
    >> Share

  121. ZHU M, Wang X, Zhang D, Chen A, et al
    Global, regional, and national burdens of five main digestive system cancers in adolescents and young adults from 1990 to 2021 based on the Global Burden of Disease Study 2021: A cross-sectional study.
    PLoS One. 2025;20:e0329377.
    >> Share

  122. ROUHOLLAHI MR, Aghili M, Nemati S, Mohagheghi MA, et al
    "Colorectal Cancer Care Quality in a Developing Country: Insights from a Comparison of Teaching and Non-teaching Hospitals in Iran".
    PLoS One. 2025;20:e0326796.
    >> Share

  123. READ OJ, Bre J, Zhang Y, Mullen P, et al
    A phosphoramidate modification of FUDR, NUC-3373, causes DNA damage and DAMPs release from colorectal cancer cells, potentiating lymphocyte-induced cell death.
    PLoS One. 2025;20:e0331567.
    >> Share

  124. BIE Y, Bie M, Liu W, Tao S, et al
    ZBTB7A regulates CD95-mediated cell growth in colorectal cancer cell lines.
    PLoS One. 2025;20:e0329958.
    >> Share

  125. LEE JO, Kim CY, Lee S, Chung JH, et al
    Multi-cancer analysis of histopathologic MSI screening based on digital histology image.
    PLoS One. 2025;20:e0332034.
    >> Share

  126. NAES SM, Ab-Rahim S, Mazlan M, Syafruddin SE, et al
    CRISPR/Cas9 mediated ENT2 gene knockout altered purine catabolic pathway and induced apoptosis in colorectal cell lines.
    PLoS One. 2025;20:e0329501.
    >> Share

  127. ALSHAHRANI MM
    Structural stability-guided scaffold hopping and computational modeling of tankyrase inhibitors targeting colorectal cancer.
    PLoS One. 2025;20:e0332798.
    >> Share

  128. KWAO-ZIGAH G, Bediako-Bowan A, Atampugbire GA, Kwayisi-Darkwah CK, et al
    Association of serum intestinal fatty-acid binding protein, inflammatory and oxidative stress markers with colorectal cancer among Ghanaian patients.
    PLoS One. 2025;20:e0333799.
    >> Share

  129. WU W, Mols F, Bonhof CS, Maas L, et al
    Association of ageing-related biomarkers with peripheral neuropathy in colorectal cancer patients up to 2 years after diagnosis.
    PLoS One. 2025;20:e0332579.
    >> Share

  130. YUAN W, Liu L
    Immune subtyping of lymph node metastasis-negative colorectal cancer reveals biomarkers for prognosis and immunotherapy response.
    PLoS One. 2025;20:e0332915.
    >> Share

  131. BARDAWEEL SK, Abu Sneineh B, Hajjo R, Abu Khalaf R, et al
    DPP4 inhibitors as a novel therapeutic strategy in colorectal cancer: Integrating network biology and experimental insights.
    PLoS One. 2025;20:e0334223.
    >> Share

  132. ABU ALSAMEN DR, Zakaraya ZZ, Abed A, Alsa'd AA, et al
    Synergistic anticancer effects of ABT-199 and Vorinostat encapsulated in PLGA nanoparticles: Formulation, characterization, and antiproliferative effects against colorectal cancer cells.
    PLoS One. 2025;20:e0334427.
    >> Share

  133. MALAGON M, Ramio-Pujol S, Serrano M, Amoedo J, et al
    Correction: New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.
    PLoS One. 2025;20:e0334314.
    >> Share

  134. CAO Y, Yang L, Fan L, Liu X, et al
    Trends in incidence, mortality and disability-adjusted life years of colorectal cancer in East Asia (1990-2021): An analysis of the Global Burden of Disease study 2021.
    PLoS One. 2025;20:e0334229.
    >> Share

  135. MORSHNEVA A, Gnedina O, Igotti M
    An in vitro tumor recurrence model based on platinum-resistant colon cancer cells as a research tool for studying cancer cell dormancy.
    PLoS One. 2025;20:e0333671.
    >> Share

  136. VAHED IE, Esmaili Z, Mamaghani MP, Farshid S, et al
    The association between serum lipid levels and colorectal cancer risk: A dose-response meta-analysis of 23 studies.
    PLoS One. 2025;20:e0333907.
    >> Share

  137. YEW WN, Dean CJ, Chan DKH
    STAG2 mutations in the normal colon induce upregulation of oncogenic pathways in neighbouring wildtype cells.
    PLoS One. 2025;20:pone.
    >> Share

  138. BUJANG NNA, Kong YC, Thiagarajan M, Roslani AC, et al
    Development and validation of a dual language needs assessment tool for people living with colorectal cancer (NeAT-CC).
    PLoS One. 2025;20:e0332930.
    >> Share

  139. LAVRINENKO V, Donskaya I, Popov V, Litau E, et al
    Phenotypic profiling of small molecules using cell painting assay in HCT116 colorectal cancer cells.
    PLoS One. 2025;20:e0334025.
    >> Share

  140. LIU Q, Lei Y, Liu Z, Han J, et al
    Integrative GWAS and RNA-Seq analysis for target identification and virtual drug screening in colorectal cancer.
    PLoS One. 2025;20:e0333179.
    >> Share

  141. ISHII M, Itano O, Iwamoto H, Takami Y, et al
    Hepatic arterial infusion is effective in patients with unresectable colorectal liver metastases refractory to standard systemic chemotherapy: A retrospective cohort study.
    PLoS One. 2025;20:e0336230.
    >> Share

  142. KARAKAYALI F, Arslan C, Bisgin T, Erenler Bayraktar I, et al
    Can neoadjuvant chemoradiotherapy be omitted in cT2N+ and cT3 mid-rectal cancer: Protocol for a prospective, observational, cohort study (CANO).
    PLoS One. 2025;20:e0321819.
    >> Share

  143. SHARMA P, Sharma B, Noonia A, Yadav DP, et al
    Diagnosis of colorectal cancer using residual transformer with mixed attention and explainable AI.
    PLoS One. 2025;20:e0335418.
    >> Share

  144. ORENGO JC, Bierrenbach AL, Aranda Flores CE, Lopez ED, et al
    Trends in the burden of HPV-associated cancers in Mexico: An analysis from 2011 to 2019.
    PLoS One. 2025;20:e0335307.
    >> Share

  145. WANG X, Xu J, Mo L, Liu L, et al
    Closed-loop temperature management with internet of things technology support in elderly laparoscopic rectal cancer surgery: A randomised controlled trial.
    PLoS One. 2025;20:e0335993.
    >> Share

  146. TIAN Y, Zeng Y, Liu Y, Ye J, et al
    N-glycosylation of NANOG regulates stemness and apoptosis in colon cancer cells.
    PLoS One. 2025;20:e0336779.
    >> Share

  147. INOUE A, Morimoto Y, Nishizawa Y, Hashimoto M, et al
    Clinical utility of circulating tumor DNA for early detection of recurrence after curative hepatectomy in patients with colorectal cancer with liver metastases: A prospective observational study protocol (CASSIOPEIA).
    PLoS One. 2025;20:e0335591.
    >> Share

  148. ADRIANTO AA, Riwanto I, Sadhana U, Paramita DK, et al
    The efficacy of Pembrolizumab, Ipilimumab, and Nivolumab monotherapy and combination for colorectal cancer: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0307128.
    >> Share

  149. AKARAPREDEE N, Atasilp C, Sukasem C, Jinda P, et al
    Impacts of polymorphisms in drug-metabolizing enzyme and transporter genes on irinotecan toxicity and efficacy in Thai colorectal cancer patients.
    PLoS One. 2025;20:e0338442.
    >> Share

  150. SUN Y, Zhu G, Lian D, Amin B, et al
    Multi-dimensional analysis of the global burden of colorectal cancer disease from 1990 to 2021 and prediction of future trends: A comprehensive study based on the GBD database.
    PLoS One. 2025;20:e0337216.
    >> Share

  151. HOBSON LM, Martin RM, Smith-Byrne K, Davey Smith G, et al
    A protocol for using human genetic data to identify circulating protein level changes that are the causal consequence of cancer processes.
    PLoS One. 2025;20:e0312970.
    >> Share

  152. ZHOU H, Fang L
    Integrated transcriptomic analysis reveals a CEBPB-DUSP1 axis driving tumor progression in colorectal cancer.
    PLoS One. 2025;20:e0337892.
    >> Share

  153. HU J, Chen Z, Ma C, Fang Y, et al
    Analyses of the roles and potential targets of m7G-related genes in colorectal cancer using single-cell and bulk RNA sequencing data.
    PLoS One. 2025;20:e0337288.
    >> Share


  154. Correction: Additional outreach effort of providing an opportunity to obtain a kit for fecal immunochemical test during the general health check-up to improve colorectal cancer screening rate in Japan: A longitudinal study.
    PLoS One. 2025;20:e0339049.
    >> Share

  155. FAN G, Zhang K, Yang X, Ding J, et al
    Correction: Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review.
    PLoS One. 2025;20:e0338537.
    >> Share

  156. ALYABSI MS, Alqarni AH, Almutairi AF, Alhalafi MS, et al
    Comparative effectiveness of open versus laparoscopic resection in patients with locally advanced colon cancer: Inverse probability of treatment weighting approach.
    PLoS One. 2025;20:e0338741.
    >> Share

    January 2024
  157. SUN J, Frick KD, Liang H, Chow CM, et al
    Examining cancer screening disparities by race/ethnicity and insurance groups: A comparison of 2008 and 2018 National Health Interview Survey (NHIS) data in the United States.
    PLoS One. 2024;19:e0290105.
    >> Share


  158. Correction: What is your count? An observational study of lymph node counting in 2,028 colorectal cancer resections.
    PLoS One. 2024;19:e0299858.
    >> Share

  159. MOURA AR, Lopes MEG, Dantas MS, Marques AD, et al
    Spatial-temporal pattern of colorectal cancer mortality in a Northeastern Brazilian State.
    PLoS One. 2024;19:e0298100.
    >> Share


  160. Expression of Concern: Cholecystectomy can increase the risk of colorectal cancer: A meta-analysis of 10 cohort studies.
    PLoS One. 2024;19:e0300484.
    >> Share

  161. GHANIPOUR L, Jansson Palmer G, Nilsson PJ, Nordenvall C, et al
    Efficacy of hyperthermic intraperitoneal chemotherapy in colorectal cancer: A phase I and III open label randomized controlled registry-based clinical trial protocol.
    PLoS One. 2024;19:e0294018.
    >> Share

  162. KESSLER LG, Comstock B, Aiello Bowles EJ, Mou J, et al
    Protocol to measure validity and reliability of colorectal, breast, cervical and lung cancer screening questions from the 2021 National Health Interview Survey: Methodology and design.
    PLoS One. 2024;19:e0297773.
    >> Share

  163. YANG Y, Mirzaei G
    Performance analysis of data resampling on class imbalance and classification techniques on multi-omics data for cancer classification.
    PLoS One. 2024;19:e0293607.
    >> Share

  164. BOUALI A, Spissu Y, Barberis A, Fadda A, et al
    Phytochemical evaluation and exploration of some biological activities of aqueous and ethanolic extracts of two species of the genus Plantago L.
    PLoS One. 2024;19:e0298518.
    >> Share

  165. MARTINY FHJ, Bie AKL, Jauernik CP, Rahbek OJ, et al
    Deaths and cardiopulmonary events following colorectal cancer screening-A systematic review with meta-analyses.
    PLoS One. 2024;19:e0295900.
    >> Share

  166. WANG X, Wang Y, Cao X, Zhang C, et al
    Underwater versus conventional endoscopic mucosal resection for >/=10 mm sessile or flat colorectal polyps: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0299931.
    >> Share

  167. CARR M, Thompson C, Berger-Gillam T, Freedman J, et al
    Testing a faith-placed education intervention for bowel cancer screening in Muslim communities using a two-group non-randomised mixed-methods approach: Feasibility study protocol.
    PLoS One. 2024;19:e0293339.
    >> Share

  168. HOANG KD, Chen JH, Huang TW, Kang YN, et al
    Oral aspirin for preventing colorectal adenoma recurrence: A systematic review and network meta-analysis of randomized controlled trials.
    PLoS One. 2024;19:e0279784.
    >> Share

  169. TSAI MH, Cabral DN, Grunert C, Moore JX, et al
    Colorectal cancer survival disparities in the five regions of Georgia.
    PLoS One. 2024;19:e0301027.
    >> Share

  170. OKUNO K, Ikemura K, Okamoto R, Oki K, et al
    CAF-associated genes putatively representing distinct prognosis by in silico landscape of stromal components of colon cancer.
    PLoS One. 2024;19:e0299827.
    >> Share

  171. WORTHINGTON J, Sun Z, Fu R, Lew JB, et al
    COVID-related disruptions to colorectal cancer screening, diagnosis, and treatment could increase cancer Burden in Australia and Canada: A modelling study.
    PLoS One. 2024;19:e0296945.
    >> Share

  172. LIANG Y, Zhang X, Li S, Wang Z, et al
    Comparison of psychological interventions for anxiety, depression, fatigue and quality of life in colorectal cancer survivors: A systematic review and network meta-analysis protocol.
    PLoS One. 2024;19:e0298589.
    >> Share

  173. PUSPITANINGTYAS H, Hutajulu SH, Fachiroh J, Anggorowati N, et al
    Diverging likelihood of colon and rectal cancer in Yogyakarta, Indonesia: A cross sectional study.
    PLoS One. 2024;19:e0301191.
    >> Share

  174. CHONG DW, Jayaraj VJ, Ab Rahim FI, Syed Soffian SS, et al
    Study protocol for a mixed methods approach to optimize colorectal cancer screening in Malaysia: Integrating stakeholders insights and knowledge-to-action framework.
    PLoS One. 2024;19:e0299659.
    >> Share

  175. RUMIN S, Han X, Zeng C, Lv F, et al
    Systematic analysis of cuproptosis abnormalities and functional significance in cancer.
    PLoS One. 2024;19:e0300626.
    >> Share

  176. MAEKAWA M, Tanaka A, Ogawa M, Roehrl MH, et al
    Propensity score matching as an effective strategy for biomarker cohort design and omics data analysis.
    PLoS One. 2024;19:e0302109.
    >> Share

  177. OGAWA M, Tanaka A, Maekawa M, Namba K, et al
    Protein expression of the amino acid transporter SLC7A5 in tumor tissue is prognostic in early-stage colorectal cancer.
    PLoS One. 2024;19:e0298362.
    >> Share

  178. DENG Q, He B, Gao T, Pan Y, et al
    Correction: Up-Regulation of 91H Promotes Tumor Metastasis and Predicts Poor Prognosis for Patients with Colorectal Cancer.
    PLoS One. 2024;19:e0304249.
    >> Share

  179. ZAIKA V, Prakash MK, Cheng CY, Schlander M, et al
    Optimal timing of a colonoscopy screening schedule depends on adenoma detection, adenoma risk, adherence to screening and the screening objective: A microsimulation study.
    PLoS One. 2024;19:e0304374.
    >> Share

  180. SU Q, Shen J
    Predictive role of preoperative sarcopenia for long-term survival in rectal cancer patients: A meta-analysis.
    PLoS One. 2024;19:e0303494.
    >> Share

  181. HUANG Z, Hu X, Wei Y, Lai Y, et al
    ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification.
    PLoS One. 2024;19:e0303909.
    >> Share

  182. CHAOUCH MA, Hussain MI, Carneiro da Costa A, Mazzotta A, et al
    Robotic versus laparoscopic total mesorectal excision with lateral lymph node dissection for advanced rectal cancer: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0304031.
    >> Share

  183. MAHDOUANI M, Zhuri D, Sezginer Guler H, Hmida D, et al
    Functional analysis of MMR gene VUS from potential Lynch syndrome patients.
    PLoS One. 2024;19:e0304141.
    >> Share

  184. FIRESTEIN R, Blander G, Michan S, Oberdoerffer P, et al
    Correction: The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth.
    PLoS One. 2024;19:e0305277.
    >> Share

  185. SEUFFERLEIN T, Lausser L, Stein A, Arnold D, et al
    Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer-Results of the prospective multicenter PERMAD trial.
    PLoS One. 2024;19:e0304324.
    >> Share

  186. PROMSUT K, Sangtanoo P, Srimongkol P, Saisavoey T, et al
    A novel peptide derived from Zingiber cassumunar rhizomes exhibits anticancer activity against the colon adenocarcinoma cells (Caco-2) via the induction of intrinsic apoptosis signaling.
    PLoS One. 2024;19:e0304701.
    >> Share

  187. DARWISH MK, Allayeh AK, Ahmed AE, Abdelmaksoud MDE, et al
    Case-control study: Unveiling human polyomaviruses and papillomavirus in Egyptian colorectal cancer patients.
    PLoS One. 2024;19:e0304147.
    >> Share

  188. BOSCH NM, Kalkdijk-Dijkstra AJ, Broens PMA, van Westreenen HL, et al
    Implementation of Pelvic Floor Rehabilitation after rectal cancer surgery: A qualitative study guided by the Consolidated Framework for Implementation Research (CFIR).
    PLoS One. 2024;19:e0301518.
    >> Share

  189. JIRAPONGWATTANA N, Thongchot S, Pongpaibul A, Trakarnsanga A, et al
    The combined tumour-based Fascin/Snail and stromal periostin reveals the effective prognosis prediction in colorectal cancer patients.
    PLoS One. 2024;19:e0304666.
    >> Share

  190. ZHANG X, Li W, Wang X, Lin J, et al
    Effectiveness of D-dimer in predicting distant metastasis in colorectal cancer.
    PLoS One. 2024;19:e0306909.
    >> Share

  191. LIN L, Fang Y, Huang F, Zhang X, et al
    Discharge teaching quality positively predicts quality of life in colorectal cancer patients with temporary enterostomy: The mediating role of readiness for hospital discharge and stoma self-efficacy.
    PLoS One. 2024;19:e0306981.
    >> Share

  192. HUANG X, Wang L, Jiang S, Xu L, et al
    DHAFormer: Dual-channel hybrid attention network with transformer for polyp segmentation.
    PLoS One. 2024;19:e0306596.
    >> Share

  193. LOVALL C, Mjelde LME, Eide LSP, Reime MH, et al
    Patients' experiences of living with low anterior resection syndrome three to six months after colorectal cancer surgery: A phenomenological study.
    PLoS One. 2024;19:e0305212.
    >> Share

  194. YUSUF H, Gupta V, Osaghae I, Kumar A, et al
    Longitudinal impact of screening colonoscopy on greenhouse gas emissions.
    PLoS One. 2024;19:e0307133.
    >> Share

  195. YANG C, Chang Z, Dai Y, Mo J, et al
    Trans-ancestry analysis in over 799,000 individuals yields new insights into the genetic etiology of colorectal cancer.
    PLoS One. 2024;19:e0301811.
    >> Share

  196. WU CY, Zhong WJ, Ye K
    Preliminary study of indocyanine green-guided laparoscopic lateral lymph node dissection for rectal cancer.
    PLoS One. 2024;19:e0307077.
    >> Share

  197. AJAB SM, Zoughbor SH, Labania LA, Ostlundh LM, et al
    Microbiota composition effect on immunotherapy outcomes in colorectal cancer patients: A systematic review.
    PLoS One. 2024;19:e0307639.
    >> Share

  198. BROEKMAN M, Genders CMS, Geitenbeek RTJ, Havenga K, et al
    Unraveling the role of computed tomography derived body composition metrics on anastomotic leakages rates in rectal cancer surgery: A protocol for a systematic review and meta-analysis.
    PLoS One. 2024;19:e0307606.
    >> Share

  199. KHANAL M, Acharya A, Maharjan R, Gyawali K, et al
    Identification of potent inhibitors of HDAC2 from herbal products for the treatment of colon cancer: Molecular docking, molecular dynamics simulation, MM/GBSA calculations, DFT studies, and pharmacokinetic analysis.
    PLoS One. 2024;19:e0307501.
    >> Share

  200. DE LAS HERAS F, Mitchell CB, Murray WK, Clemons NJ, et al
    Development of an in vivo syngeneic mouse transplant model of invasive intestinal adenocarcinoma driven by endogenous expression of Pik3caH1047R and Apc loss.
    PLoS One. 2024;19:e0308051.
    >> Share

  201. WANG G, Hiramoto K, Ma N, Ohnishi S, et al
    Immunohistochemical analyses reveal FoxP3 expressions in spleen and colorectal cancer in mice treated with AOM/DSS, and their suppression by glycyrrhizin.
    PLoS One. 2024;19:e0307038.
    >> Share

  202. NORTHROP-ALBRECHT EJ, Wu CW, Berger CK, Taylor WR, et al
    An investigation of plasma cell-free RNA for the detection of colorectal cancer: From transcriptome marker selection to targeted validation.
    PLoS One. 2024;19:e0308711.
    >> Share

  203. ALMUTAIRI MH, Alrubie TM, Alshareeda AT, Albarakati N, et al
    Differential expression and regulation of ADAD1, DMRTC2, PRSS54, SYCE1, SYCP1, TEX101, TEX48, and TMPRSS12 gene profiles in colon cancer tissues and their in vitro response to epigenetic drugs.
    PLoS One. 2024;19:e0307724.
    >> Share

  204. NG AP, Kim S, Chervu N, Gao Z, et al
    Disparities in outcomes of colorectal cancer surgery among adults with intellectual and developmental disabilities.
    PLoS One. 2024;19:e0308938.
    >> Share

  205. ZHANG M, Li W, Zhao Y, Qi L, et al
    Molecular characterization analysis of PANoptosis-related genes in colorectal cancer based on bioinformatic analysis.
    PLoS One. 2024;19:e0307651.
    >> Share

  206. BALTA B, Taylor L, Bogale N, Hailu D, et al
    Survival and predictors of mortality among colorectal cancer patients on follow-up in Hawassa University Comprehensive Specialized Hospital, Sidama region, Southern Ethiopia, 2022. A 5-year retrospective cohort study.
    PLoS One. 2024;19:e0304820.
    >> Share

  207. OGUNDIPE O, Kurt Z, Woo WL
    Deep neural networks integrating genomics and histopathological images for predicting stages and survival time-to-event in colon cancer.
    PLoS One. 2024;19:e0305268.
    >> Share

  208. MONTAGNON E, Cerny M, Hamilton V, Derennes T, et al
    Radiomics analysis of baseline computed tomography to predict oncological outcomes in patients treated for resectable colorectal cancer liver metastasis.
    PLoS One. 2024;19:e0307815.
    >> Share

  209. PERRIN ML, Bassetti C, Durand Fontanier S, Yardin C, et al
    Effects of HyaRegen gel on tumour proliferation of colorectal peritoneal metastases.
    PLoS One. 2024;19:e0307965.
    >> Share

  210. HEZI H, Shats D, Gurevich D, Maruvka YE, et al
    Exploring the interplay between colorectal cancer subtypes genomic variants and cellular morphology: A deep-learning approach.
    PLoS One. 2024;19:e0309380.
    >> Share

  211. CHEN XF, Liu PG, Sheng N, Li XS, et al
    Arctigenin inhibits the progression of colorectal cancer through epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway.
    PLoS One. 2024;19:e0308947.
    >> Share

  212. MA T, Qin Z, Xu G, Zheng PW, et al
    Negative prognostic impact of tumor deposits in stage III colorectal cancer patients.
    PLoS One. 2024;19:e0310327.
    >> Share

  213. AHMAD MS, Braoudaki M, Siddiqui SS
    Differential expression of ST6GALNAC1 and ST6GALNAC2 and their clinical relevance to colorectal cancer progression.
    PLoS One. 2024;19:e0311212.
    >> Share

  214. TAN J, Yuan J, Fu X, Bai Y, et al
    Colonoscopy polyp classification via enhanced scattering wavelet Convolutional Neural Network.
    PLoS One. 2024;19:e0302800.
    >> Share

  215. WONGPRAYOON P, Pengnam S, Srisuphan R, Opanasopit P, et al
    The correlation between cellular O-GlcNAcylation and sensitivity to O-GlcNAc inhibitor in colorectal cancer cells.
    PLoS One. 2024;19:e0312173.
    >> Share

  216. SAHEBNASAGH R, Deli H, Shadboorestan A, Vakili-Ghartavol Z, et al
    Identification of key lncRNAs associated with oxaliplatin resistance in colorectal cancer cells and isolated exosomes: From In-Silico prediction to In-Vitro validation.
    PLoS One. 2024;19:e0311680.
    >> Share

  217. GARCIA MENENDEZ G, Sichel L, Lopez MDC, Hernandez Y, et al
    From colon wall to tumor niche: Unraveling the microbiome's role in colorectal cancer progression.
    PLoS One. 2024;19:e0311233.
    >> Share

  218. SIDDIQUE S, Baum LVM, Deziel NC, Kelly JR, et al
    Using a Bayesian analytic approach to identify county-level ecological factors associated with survival among individuals with early-onset colorectal cancer.
    PLoS One. 2024;19:e0311540.
    >> Share

  219. MASROUR M, Khanmohammadi S, Habibzadeh A, Fallahtafti P, et al
    LncRNA MALAT1 as diagnostic and prognostic biomarker in colorectal cancers: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0308009.
    >> Share

  220. LI R, Chen J, Shen X, Lin Y, et al
    A study of the clinical significance of mSEPT9 in monitoring recurrence and prognosis in patients with surgically treated colorectal cancer.
    PLoS One. 2024;19:e0312676.
    >> Share

  221. MOUSAVI KAHAKI SA, Ebrahimzadeh N, Fahimi H, Moshiri A, et al
    Development of an optimized protocol for generating knockout cancer cell lines using the CRISPR/Cas9 system, with emphasis on transient transfection.
    PLoS One. 2024;19:e0310368.
    >> Share

  222. LAL A, Mohebi M, Wyatt K, Ghosh A, et al
    Tailored recruitment interventions to improve bowel cancer screening in Arabic and Mandarin speaking groups: Modelled cost-effectiveness.
    PLoS One. 2024;19:e0313058.
    >> Share

  223. ZHU Z, Lam TYT, Tang RSY, Wong SH, et al
    Triglyceride-glucose index (TyG index) is associated with a higher risk of colorectal adenoma and multiple adenomas in asymptomatic subjects.
    PLoS One. 2024;19:e0310526.
    >> Share


  224. Expression of Concern: Curcumin Enhances the Effect of Chemotherapy against Colorectal Cancer Cells by Inhibition of NF-kappaB and Src Protein Kinase Signaling Pathways.
    PLoS One. 2024;19:e0314637.
    >> Share

  225. CORREA-MEDERO RL, Pai R, Ebare K, Buchanan DD, et al
    Causal debiasing for unknown bias in histopathology-A colon cancer use case.
    PLoS One. 2024;19:e0303415.
    >> Share

  226. GHOBASHI AH, Kimani JW, Ladaika CA, O'Hagan HM, et al
    PTEN depletion reduces H3K27me3 levels to promote epithelial-to-mesenchymal transition in epithelial colorectal cancer cells.
    PLoS One. 2024;19:e0313769.
    >> Share

  227. DENG LQ, Li SY, Xie T, Zeng WQ, et al
    LincROR promotes tumor growth of colorectal cancer through the miR-145/WNT2B/WNT10A/Wnt/beta-catenin regulatory axis.
    PLoS One. 2024;19:e0312417.
    >> Share

  228. ESFANDIARI F, Bakhshi B, Shahbazi T, Derakhshan-Nezhad E, et al
    Significant difference in gut microbiota Bifidobacterium species but not Lactobacillus species in colorectal cancer patients in comparison with healthy volunteers using quantitative real-time PCR.
    PLoS One. 2024;19:e0294053.
    >> Share

  229. WEINSTEIN SJ, Parisi D, Mondul AM, Layne TM, et al
    Vitamin D binding protein genetic isoforms, serum vitamin D, and cancer risk in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    PLoS One. 2024;19:e0315252.
    >> Share

  230. OKAWA M, Yamakuchi M, Bibek A, Takenouchi K, et al
    Plasma and serum concentrations of VEGF-A121, but not of VEGF-A165, increase post-bevacizumab administration.
    PLoS One. 2024;19:e0316035.
    >> Share

  231. AISU Y, Oshima N, Hyodo F, Elhelaly AE, et al
    Dual inhibition of oxidative phosphorylation and glycolysis exerts a synergistic antitumor effect on colorectal and gastric cancer by creating energy depletion and preventing metabolic switch.
    PLoS One. 2024;19:e0309700.
    >> Share

  232. ZHANG H, Yi H, Qin S, Liu X, et al
    CLIP-based multimodal endorectal ultrasound enhances prediction of neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
    PLoS One. 2024;19:e0315339.
    >> Share

  233. KORSIRIKOON C, Techaniyom P, Kettawan A, Rungruang T, et al
    Cold-pressed extraction of perilla seed oil enriched with alpha-linolenic acid mitigates tumour progression and restores gut microbial homeostasis in the AOM/DSS mice model of colitis-associated colorectal cancer.
    PLoS One. 2024;19:e0315172.
    >> Share

  234. SUN C, Fan E, Huang L, Zhang Z, et al
    Second-line systemic treatment for metastatic colorectal cancer: A systematic review and Bayesian network meta-analysis based on RCT.
    PLoS One. 2024;19:e0313278.
    >> Share

  235. WANG D, Wang J, Yao F, Xie Z, et al
    miR-1247-3p regulation of CCND1 affects chemoresistance in colorectal cancer.
    PLoS One. 2024;19:e0309979.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016